(Q43594329)

25 November 2017

title

Influence of sibutramine on energy expenditure in African American women (English)

1 reference

25 November 2017

1 reference

Starling RD

1

1 reference

25 November 2017

Liu X

series ordinal

2

1 reference

25 November 2017

Sullivan DH

series ordinal

3

1 reference

25 November 2017

publication date

1 April 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

9

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

251-256

1 reference

Sibutramine: a novel new agent for obesity treatment

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Effects of sibutramine on resting metabolic rate and weight loss in overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Adrenergic control of post-exercise metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Does moderate aerobic activity have a stimulatory effect on 24 h resting energy expenditure: a direct calorimeter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Reduced rate of energy expenditure as a risk factor for body-weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Thermogenic effects of sibutramine and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Resting metabolic rate in obese, premenopausal black women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Differences in resting metabolic rates of inactive obese African-American and Caucasian women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Resting energy expenditure in obese African American and Caucasian women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Differences in resting energy expenditure in African-American vs Caucasian overweight females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Energy metabolism in African Americans: potential risk factors for obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Sibutramine reduces food intake in non-dieting women with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Thermogenic effects of sibutramine in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Effect of beta-adrenoceptor blockade on post-exercise oxygen consumption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Effect of beta-adrenoceptor stimulation on oxygen consumption and triglyceride/fatty acid cycling after exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2001.29

31 March 2020

Identifiers

DOI

10.1038/OBY.2001.29

1 reference

25 November 2017

1 reference